Outset Medical Debt to Equity Ratio 2019-2025 | OM
Current and historical debt to equity ratio values for Outset Medical (OM) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Outset Medical debt/equity for the three months ending March 31, 2025 was 0.57.
| Outset Medical Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-03-31 | $0.13B | $0.17B | 0.77 |
| 2024-12-31 | $0.25B | $0.03B | 9.28 |
| 2024-09-30 | $0.25B | $0.05B | 5.13 |
| 2024-06-30 | $0.25B | $0.07B | 3.59 |
| 2024-03-31 | $0.25B | $0.09B | 2.72 |
| 2023-12-31 | $0.19B | $0.12B | 1.55 |
| 2023-09-30 | $0.16B | $0.15B | 1.02 |
| 2023-06-30 | $0.15B | $0.18B | 0.83 |
| 2023-03-31 | $0.15B | $0.22B | 0.68 |
| 2022-12-31 | $0.15B | $0.25B | 0.63 |
| 2022-09-30 | $0.09B | $0.28B | 0.31 |
| 2022-06-30 | $0.09B | $0.31B | 0.30 |
| 2022-03-31 | $0.09B | $0.35B | 0.25 |
| 2021-12-31 | $0.09B | $0.37B | 0.24 |
| 2021-09-30 | $0.08B | $0.41B | 0.19 |
| 2021-06-30 | $0.07B | $0.43B | 0.17 |
| 2021-03-31 | $0.07B | $0.31B | 0.24 |
| 2020-12-31 | $0.08B | $0.33B | 0.23 |
| 2020-09-30 | $0.07B | $0.35B | 0.20 |
| 2020-06-30 | $0.00B | $0.00B | 0.00 |
| 2020-03-31 | $0.00B | $0.00B | 0.00 |
| 2019-12-31 | $0.00B | 0.00 | |
| 2019-09-30 | $0.00B | $0.00B | 0.00 |
| 2018-12-31 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.316B | $0.114B |
| Outset Medical Inc. is a medical technology company. Its Tablo(R) Hemodialysis System represents technological advancement enabling novel, transformational dialysis care in acute and home settings. Outset Medical Inc. is based in CA, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.332B | 57.93 |
| Hims & Hers Health (HIMS) | United States | $12.707B | 132.02 |
| Tempus AI (TEM) | United States | $10.988B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.490B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.944B | 61.63 |
| Hinge Health (HNGE) | United States | $3.156B | 0.00 |
| Privia Health (PRVA) | United States | $2.783B | 190.25 |
| Enovis (ENOV) | United States | $1.694B | 9.44 |
| Clover Health Investments (CLOV) | United States | $1.613B | 0.00 |
| Schrodinger (SDGR) | United States | $1.592B | 0.00 |
| Phreesia (PHR) | United States | $1.482B | 0.00 |
| Omnicell (OMCL) | United States | $1.415B | 24.96 |
| Azenta (AZTA) | United States | $1.219B | 56.66 |
| 10x Genomics (TXG) | United States | $1.164B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.629B | 0.00 |
| Claritev (CTEV) | United States | $0.629B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.571B | 0.00 |
| Talkspace (TALK) | United States | $0.561B | 167.50 |
| Veradigm (MDRX) | United States | $0.466B | 0.00 |
| Standard BioTools (LAB) | United States | $0.399B | 0.00 |
| TruBridge (TBRG) | United States | $0.357B | 791.67 |
| Health Catalyst (HCAT) | United States | $0.264B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.260B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.194B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.136B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.129B | 0.00 |
| Pulmonx (LUNG) | United States | $0.126B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.104B | 0.00 |
| American Well (AMWL) | United States | $0.103B | 0.00 |
| CareCloud (CCLD) | United States | $0.085B | 3.26 |
| 111 (YI) | China | $0.070B | 0.00 |
| HeartBeam (BEAT) | United States | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.051B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.034B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Precipio (PRPO) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |